PCAS

Earnings Release • Nov 6, 2013

Longjumeau, November 6, 2013

(in thousands of euros)	2012 published (including SBS)	2012 restated (without SBS)	2013	% change
First Quarter	42 728	41 809	43 033	+ 2.9%
including Pharmaceutical Synthesis	25 454	25 454	26 677	+ 4.8%
including Fine Speciality Chemicals	17 274	16 355	16 356	0.0%
Second Quarter	46 633	45 697	46 011	+ 0.7%
including Pharmaceutical Synthesis	29 910	29 910	31 400	+ 5.0%
including Fine Speciality Chemicals	16 723	15 787	14 611	- 7.4%
Third Quarter	38 355	37 689	37 897	+ 0.6%
including Pharmaceutical Synthesis	23 298	23 298	23 784	+ 2.1%
including Fine Specialty Chemicals	15 057	14 391	14 113	- 1.9%
Total as of 30 September	127 716	125 195	126 941	+ 1.4%
including Pharmaceutical Synthesis	78 662	78 662	81 861	+ 4.1%
including Fine Speciality Chemicals	49 054	46 533	45 080	- 3.1%

As a reminder, the sale of SBS was finalized on March 20, 2013. SBS has been presented on a specific "Net result after tax of activities destined to be sold" line on December 31, 2012.

Consolidated revenue for the PCAS Group is up 1.4% at September 30, 2013 compared to the same period for the previous year.

Pharmaceutical Synthesis

Pharmaceutical Synthesis activities over the first nine months of 2013 are up 4.1% compared to 2012.

Fine Specialty Chemicals

There was a drop in Fine Specialty Chemicals activities at September 30, 2013 compared to September 30, 2012 (-3.1%), this segment having been affected by a marked slow-down in New Technologies activities, while Performance Chemicals and Fragrances, Flavors, Cosmetics activities continued to grow over the same period.

Business in the last quarter of 2013 is expected to be down compared to the last quarter of 2012, affected by customers caution, both for Pharmaceutical Synthesis and Fine Specialty Chemicals activities.

Overall, 2013 is likely to close with a turnover lower than that recorded in 2012.

About PCAS:

Founded in 1962, PCAS is an international fine and specialty chemicals group that shares an ambition for excellence with its customers, which primarily include market-leading international groups. PCAS designs and delivers the best industrial solutions for its customers' specific expectations. These various expectations all share a common demand for safety, quality, competitiveness, innovation and sustainability. PCAS also develops ranges of proprietary products based on intellectual property.